Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
5.08
+0.13 (2.63%)
At close: Apr 28, 2026, 4:00 PM EDT
5.00
-0.08 (-1.57%)
After-hours: Apr 28, 2026, 6:02 PM EDT
Strata Critical Medical Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Strata Critical Medical stock have an average target of 7.81, with a low estimate of 7.25 and a high estimate of 8.00. The average target predicts an increase of 53.74% from the current stock price of 5.08.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 25, 2026.
Analyst Ratings
The average analyst rating for Strata Critical Medical stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +57.48% | Mar 25, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +57.48% | Mar 25, 2026 |
| Lake Street | Lake Street | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +57.48% | Dec 2, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $6.5 → $7.25 | Strong Buy | Maintains | $6.5 → $7.25 | +42.72% | Sep 17, 2025 |
Financial Forecast
Revenue This Year
274.56M
from 197.14M
Increased by 39.27%
Revenue Next Year
299.52M
from 274.56M
Increased by 9.09%
EPS This Year
-0.10
from 0.50
EPS Next Year
-0.01
from -0.10
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 284.0M | 308.5M |
| Avg | 274.6M | 299.5M |
| Low | 262.7M | 287.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 44.1% | 12.4% |
| Avg | 39.3% | 9.1% |
| Low | 33.3% | 4.8% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.07 | -0.01 |
| Avg | -0.10 | -0.01 |
| Low | -0.14 | -0.01 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.